We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Finch Therapeutics Group Inc
11 own
16 watching
Current Price
$2.18
$-0.05
(-2.24%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
6.16M
52-Week High
16.74000
52-Week Low
1.86000
Average Volume
0.02M
Dividend Yield
--
P/E Ratio
--
Market Capitalization6.16M52-Week High16.7400052-Week Low1.86000Average Volume0.02MDividend Yield--P/E Ratio--What does the Finch Therapeutics Group Inc do?
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company s lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism spectrum disorder; and TAK-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and Crohn's disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.
Read More
How much money does Finch Therapeutics Group Inc make?
News & Events about Finch Therapeutics Group Inc.
PR Newswire
10 months ago
Thinking about buying stock in T Rowe Price, Ross Stores, Davita, Catalent, or Finch Therapeutics? Thinking about buying stock in T Rowe Price, Ross Stores, Davita, Catalent, or Finch Therapeutics? PR Newswire NEW YORK, June 13, 2023 NEW YORK, June 13, 2023 /PRNewswire/ -- InvestorsObserver issues...
Globe Newswire
11 months ago
BOSTON, June 09, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (Finch, Finch Therapeutics or the Company) (Nasdaq: FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today announced it will effect a one-for-30 reverse stock split of its ...
Zolmax
1 year ago
Atara Biotherapeutics (NASDAQ:ATRA Get Rating) and Finch Therapeutics Group (NASDAQ:FNCH Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, ...
Globe Newswire
1 year ago
SOMERVILLE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (the Company, Finch, or Finch Therapeutics) (Nasdaq: FNCH) today announced its decision to discontinue the PRISM4 Phase 3 trial of CP101 in recurrent C. difficile infection (CDI) and focus on realizing the value of ...
Globe Newswire
1 year ago
SOMERVILLE, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (Finch or Finch Therapeutics) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs, today ...
Frequently Asked Questions
Frequently Asked Questions
What is Finch Therapeutics Group Inc share price today?
Can Indians buy Finch Therapeutics Group Inc shares?
How can I buy Finch Therapeutics Group Inc shares from India?
Can Fractional shares of Finch Therapeutics Group Inc be purchased?
What are the documents required to start investing in Finch Therapeutics Group Inc stocks?
What is today’s traded volume of Finch Therapeutics Group Inc?
What is today’s market capitalisation of Finch Therapeutics Group Inc?
What is the 52-Week High and Low Range of Finch Therapeutics Group Inc?
What percentage is Finch Therapeutics Group Inc down from its 52-Week High?
What percentage is Finch Therapeutics Group Inc up from its 52-Week Low?
Current Price
$2.18
$-0.05
(-2.24%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.